Z-1150-2021 Class II Terminated
FDA device recall Z-1150-2021 was initiated by Baxter Healthcare Corporation on Jan 6, 2021 and is designated Class II. Reason for recall: Battery performance issues related to prolonged storage. The recall status is terminated (terminated May 4, 2026). Affected quantity: 589,704 total units.
Recall details
- Product Type
- Devices
- Report Date
- Mar 3, 2021
- Initiation Date
- Jan 6, 2021
- Termination Date
- May 4, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 589,704 total units
Product description
Reason for recall
Distribution pattern
Domestic Distribution: ST, AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and Puerto Rico. International Distribution: Canada, Barbados, Bermuda, St. Thomas, Guyana, Trinidad and Tobago, Jamaica and Nassau Bahamas.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1150-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026